Lv73
3500 积分 2022-11-21 加入
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
1天前
已完结
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study
1天前
已完结
Antibody Drug Conjugates in Multiple Myeloma
2天前
已完结
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma
2天前
已完结
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference
2个月前
已完结
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
2个月前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
5个月前
已完结
异甘草酸镁对化疗药物致初治胃肠道肿瘤患者肝损害的预防作用
6个月前
已完结
Advances in Causes and Treatment of Autism
6个月前
已完结
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
9个月前
已关闭
皖公网安备34019202002308
